Ibogaine

Iboga, ibogaine, noribogaine & 18-MC

 

 

Jump to:

 

 

Page 1
(1955-1995)

Turner, Merlis & Carl (1955). Concerning theories of indoles in schizophrenigenesis. The American Journal of Psychiatry.

Dhahir, Jain & Forney (1971). Methods for the detection and determination of ibogaine in biological materials. Journal of Forensic Sciences.

Cartoni & Giarusso (1972). Gas chromatographic determination of ibogaine in biological fluids. Journal of Chromatography.

Dhahir, Jain & Thornton (1972). The identification of ibogaine in biological material. Journal of the Foresnic Science Society.

Zetler (1983). Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine. A comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and clonazepam. Neuropharmacology.

Bert et al. (1988). Non-amphetaminic central stimulation by alkaloids from the ibogane an vobasine series. Planta Medica.

Dzoljic, Kaplan & Dzoljic (1988). Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats. Archives Internationales de Pharmacodynamie et de Therapie.

Sharpe & Jaffe (1990). Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine-dependent rat. Neuroreport.

Glick et al. (1991). Effects and aftereffects of ibogaine on morphine self-administration in rats. European Journal of Pharmacology.

Maisonneuve, Keller & Glick (1991). Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study. European Journal of Pharmacology.

Deecher et al. (1992). Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies. Brain Research.

Francés et al.  (1992). Effects of ibogaine on naloxone-precipitated withdrawal in morphine-dependent mice. Fundamental & Clinical Pharmacology.

Glick et al. (1992). Differential effects of ibogaine pretreatment on brain levels of morphine and (+)-amphetamine. Brain Research.

Glick et al. (1992). Effects of ibogaine on acute signs of morphine withdrawal in rats: Independence from tremor. Neuropharmacology.

Maisonneuve et al. (1992). Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats. Brain Research.

Maisonneuve, Keller & Glick (1992). Interactions of ibogaine and D-amphetamine: In vivo microdialysis and motor behavior in rats. Brain Research.

Maisonneuve & Glick (1992). Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior. European Journal of Pharmacology.

Palumbo & Winter (1992). Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD. Pharmacology, Biochemistry and Behavior.

Sershen et al. (1992). Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats. Life Sciences.

Sershen et al. (1992). Ibogaine antagonizes cocaine-induced locomotor stimulation in mice. Life Sciences.

Cappendijk & Dzoljic (1993). Inhibitory effects of ibogaine on cocaine self-administration in rats. European Journal of Pharmacology.

Glick et al. (1993). Local effects of ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum: interactions with D-amphetamine. Brain Research.

O’Hearn & Molliver (1993). Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience.

O’Hearn, Long & Molliver (1993). Ibogaine induces glial activation in parasagittal zones of the cerebellum. Neuroreport.

Schechter & Gordon (1993). Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity. European Journal of Pharmacology.

Broderick et al. (1994). Ibogaine modulates cocaine responses which are altered due to environmental habituation: In vivo microvoltammetric and behavioral studies. Pharmacology, Biochemistry and Behavior.

Cappendijk, Fekkes & Dzoljic (1994). The inhibitory effect of norharman on morphine withdrawal syndrome in rats: Comparison with ibogaine. Behavioural Brain Research.

Glick et al. (1994). Effects of iboga alkaloids on morphine and cocaine self-administration in rats: Relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum. Brain Research.

Harsing, Sershen & Lajtha (1994). Evidence that ibogaine releases dopamine from the cytoplasmic pool in isolated mouse striatum. Journal of Neural Transmission.

Popik, Layer & Skolnick (1994). The putative anti-addictive drug ibogaine is a competitive inhibitor of [–3H]MK-801 binding to the NMDA receptor complex. Psychopharmacology.

Sershen, Hashim & Lajtha (1994). Ibogaine reduces preference for cocaine consumption in C57BL/6By mice. Pharmacology, Biochemistry and Behavior.

Sershen, Hashim & Lajtha (1994). Effect of ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats. Neurochemical Research.

Sheppard (1994). A preliminary investigation of ibogaine: Case reports and recommendations for further study. Journal of Substance Abuse Treatment.

Alburges, Foltz & Moody (1995). Determination of ibogaine and 12-hydroxy-ibogamine in plasma by gas chromatography-positive ion chemical ionization-mass spectrometry. Journal of Analytical Toxicology.

Bowen et al. (1995). Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity. European Journal of Pharmacology.

Codd (1995). High affinity ibogaine binding to a mu opioid agonist site. Life Sciences.

Dworkin et al. (1995). Effects of ibogaine on responding maintained by food, cocaine and heroin reinforcement in rats. Psychopharmacology.

Gallagher et al. (1995). Identification and quantification of the indole alkaloid ibogaine in biological samples by gas chromatography-mass spectrometry. Biochemical Pharmacology.

Hearn et al. (1995). Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry. Journal of Analytical Toxicology.

House, Thomas & Bhargava (1995). Comparison of the hallucinogenic indole alkaloids ibogaine and harmaline for potential immunomodulatory activity. Pharmacology.

Kesner et al. (1995). Effects of ibogaine on sensory-motor function, activity, and spatial learning in rats. Pharmacology, Biochemistry and Behavior.

Mach, Smith & Childers (1995). Ibogaine possesses a selective affinity for sigma 2 receptors. Life Sciences.

Mash et al. (1995). Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin. Life Sciences.

Mash et al. (1995). Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex. Neuroscience Letters.

O’Hearn, Zhang & Molliver (1995). Excitotoxic insult due to ibogaine leads to delayed induction of neuronal NOS in Purkinje cells. Neuroreport.

Parker, Siegel & Luxton (1995). Ibogaine attenuates morphine-induced conditioned place preference. Experimental and Clinical Psychopharmacology.

Pearl, Johnson & Glick (1995). Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation. Psychopharmacology.

Pearl et al. (1995). Radioligand-binding study of noribogaine, a likely metabolite of ibogaine. Brain Research.

Popik et al. (1995). NMDA antagonist properties of the putative antiaddictive drug, ibogaine. The Journal of Pharmacology and Experimental Therapeutics.

Popik, Layer & Skolnick (1995). 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug. Pharmacological Reviews.